Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 955E2 | — |
trouble withdrawing the Priorix out of the vial after reconstitution; changed the needle from 25 g to 21g and still could not withdraw the vaccine out of antigen vial; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) (batch number 955E2, expiry date 13-SEP-2026) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: trouble withdrawing the Priorix out of the vial after reconstitution) and wrong technique in drug usage process (Verbatim: changed the needle from 25 g to 21g and still could not withdraw the vaccine out of antigen vial). The outcome of the inappropriate preparation of medication and wrong technique in drug usage process were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-APR-2025 The registered pharmacist reported that he had trouble withdrawing the Priorix out of the vial after reconstitution and he changed the needle from 25G to 21G and still could not withdraw the vaccine out of antigen vial and was not sure if the correct syringe was used the first time, which led to wrong technique in drug usage process and inappropriate preparation of medication. The reporter tried again and was able to withdraw the vaccine from the antigen vial and was able to administer the suspect product